http://finance.yahoo.com/news/cer-study-finds-no-observable-150700183.html
“We found that people treated with branded statins and generic statins were observed to have similar lowering of the rate of cardiovascular events,” said Jeff White, WellPoint director of drug evaluation.
“The results were generally the same whether patients were taking statins to prevent a first heart attack or other cardiovascular event or whether they took them after experiencing a heart attack,” said White. “As with most observational analyses, this study shows associations rather than cause and effect.”
“We found that people treated with branded statins and generic statins were observed to have similar lowering of the rate of cardiovascular events,” said Jeff White, WellPoint director of drug evaluation.
“The results were generally the same whether patients were taking statins to prevent a first heart attack or other cardiovascular event or whether they took them after experiencing a heart attack,” said White. “As with most observational analyses, this study shows associations rather than cause and effect.”